Evidence map›Paper›PMID 28655929›Full record

ArticleThe Journal of antibiotics2018

Discovery of 2-hydroxyarbekacin, a new aminoglycoside antibiotic with reduced nephrotoxicity.

Yoshiaki Takahashi, Eijiro Umemura, Yoshihiko Kobayashi, Shoichi Murakami, Toru Nawa, Akihiro Morinaka, Toshiaki Miyake, Masakatsu Shibasaki

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in The Journal of antibiotics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Yoshiaki TakahashiInstitute of Microbial Chemistry (BIKAKEN), Tokyo, Japan.
Eijiro UmemuraInstitute of Microbial Chemistry (BIKAKEN), Tokyo, Japan.
Yoshihiko KobayashiInstitute of Microbial Chemistry (BIKAKEN), Tokyo, Japan.
Shoichi MurakamiMeiji Seika Pharma Co., Ltd., Yokohama, Japan.
Toru NawaMeiji Seika Pharma Co., Ltd., Yokohama, Japan.
Akihiro MorinakaMeiji Seika Pharma Co., Ltd., Yokohama, Japan.
Toshiaki MiyakeInstitute of Microbial Chemistry (BIKAKEN), Tokyo, Japan.
Masakatsu ShibasakiInstitute of Microbial Chemistry (BIKAKEN), Tokyo, Japan.
Microbial Chemistry Research Foundation · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AminoglycosidesAnimalsAnti-Bacterial AgentsDrug DiscoveryKidney DiseasesKidney Function TestsLLC-PK1 CellsMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsMolecular ConformationPseudomonas aeruginosaRatsSwineAminoglycosidesAnti-Bacterial Agents

Identifiers

PMID28655929
OpenAlexW2726340259

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.